- Home
- AMBC vs TNXP Comparison
AMBC vs TNXP Comparison
Compare AMBC & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- TNXP
- Stock Information
- Founded
- AMBC 1971
- TNXP 2007
- Country
- AMBC United States
- TNXP United States
- Employees
- AMBC N/A
- TNXP N/A
- Industry
- AMBC Property-Casualty Insurers
- TNXP Biotechnology: Pharmaceutical Preparations
- Sector
- AMBC Finance
- TNXP Health Care
- Exchange
- AMBC Nasdaq
- TNXP Nasdaq
- Market Cap
- AMBC 411.3M
- TNXP 335.6M
- IPO Year
- AMBC 1991
- TNXP N/A
- Fundamental
- Price
- AMBC $8.68
- TNXP $27.58
- Analyst Decision
- AMBC Strong Buy
- TNXP Buy
- Analyst Count
- AMBC 2
- TNXP 1
- Target Price
- AMBC $12.50
- TNXP $70.00
- AVG Volume (30 Days)
- AMBC 578.9K
- TNXP 1.6M
- Earning Date
- AMBC 11-11-2025
- TNXP 11-11-2025
- Dividend Yield
- AMBC N/A
- TNXP N/A
- EPS Growth
- AMBC N/A
- TNXP N/A
- EPS
- AMBC N/A
- TNXP N/A
- Revenue
- AMBC $257,879,000.00
- TNXP $9,831,000.00
- Revenue This Year
- AMBC N/A
- TNXP $21.19
- Revenue Next Year
- AMBC $19.44
- TNXP $722.94
- P/E Ratio
- AMBC N/A
- TNXP N/A
- Revenue Growth
- AMBC 148.44
- TNXP N/A
- 52 Week Low
- AMBC $5.99
- TNXP $6.76
- 52 Week High
- AMBC $13.64
- TNXP $130.00
- Technical
- Relative Strength Index (RSI)
- AMBC 51.60
- TNXP 39.12
- Support Level
- AMBC N/A
- TNXP $26.37
- Resistance Level
- AMBC $9.28
- TNXP $31.55
- Average True Range (ATR)
- AMBC 0.27
- TNXP 2.25
- MACD
- AMBC -0.38
- TNXP 0.17
- Stochastic Oscillator
- AMBC 92.73
- TNXP 34.35
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.